Direktorat Registrasi ObatValid

DARZALEX

BPOM Number: DKI2060001549A1
Approved: 29 April 2025
Expiry: 26 April 2030
Form: LARUTAN KONSENTRAT UNTUK INFUS

About This Registration

DARZALEX is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKI2060001549A1. Its current registration status is Valid, with the licence valid until 26 April 2030. The product is registered to INTEGRATED HEALTHCARE INDONESIA - INDONESIA. BPOM first approved this registration in April 2025. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application: newaero
Packaging: DUS, 1 VIAL @ 5 ML (100 MG)
Department: Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

INTEGRATED HEALTHCARE INDONESIA - INDONESIA
KODYA JAKARTA TIMUR
NPWP: 032304875063000
owner
View profile →

Manufacturing Sites

INTEGRATED HEALTHCARE INDONESIA - INDONESIA
KODYA JAKARTA TIMUR
primary
View profile →

Ingredients (1)

DARATUMUMAB

Market Intelligence

Owner Portfolio: INTEGRATED HEALTHCARE INDONESIA - INDONESIA holds 64 BPOM registrations
Manufacturer Scale: INTEGRATED HEALTHCARE INDONESIA - INDONESIA produces 64 registered products
Registration Age: Registered for 1 year, 4 months